anti-ceaxanti-dtpa bispecific antibody
mAbexperimentalADCMulti-specific
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2004 (NCT00467506)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
CEACAM5 binding agent
- Tumor antigensBINDING AGENT
Tumor antigens binding agent
Chemistry & pharmacology
- Multi-specific
- Yes
- Payload
- 131-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- anti-ceaxanti-dtpa bispecific antibody
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00467506 | Phase 2 | May 1, 2004 | University of Nantes |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Nantes | Academic/Hospital | 1 | 1 | 1 | 2004 |
1 organizations
Page 1 / 1